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Chalcones scaffolds have attracted many researchers to investigate their 
synthetic routes, potential biological activities and their roles as intermediates for 
naturally occurring flavanoid skeletons. This study focused on the synthesis of 
chalcones bearing the O-, C-prenyl and chromane as substituents. The target 
compounds were purified by chromatographic methods and the structures of these 
compounds were determined by using infrared (IR), nuclear magnetic resonance 
(NMR) and mass spectrometry (MS) spectroscopies.  The prenylated precursors were 
synthesized starting from 2,4-dihydroxyacetophenone (65) and 2,4,6-
trihydroxyacetophenone (93). Prenylation of 2,4-dihydroxyacetophenone using 
prenyl bromide has been successfully accomplished to produce 2-hydroxy-4-O-
prenylacetophenone (101). A reaction of 2,4,6-trihydroxyacetophenone with prenyl 
bromide in the presence of base resulted in a mixture and the chromatographic 
purification gave 2,4,6-trihydroxy-3-C-prenylacetophenone (132) and 2,4-dihydroxy-
5,6-chromanacetophenone (133). Compound (133) was prenylated into 2-hydroxy-4-
O-prenyl-5,6-chromanacetophenone (136).  C-prenylated acetophenone (132) was 
then converted to 2-hydroxy-3-C-prenyl-4,6-dimethoxyacetophenone (137) using 
methyl iodide in the presence of potassium carbonate. Claisen-Schmidt condensation 
of O- and C-prenylated acetophenone with individual benzaldehydes, namely 4-
(N,N-dimethyl)aminobenzaldehyde (61), 2-methoxybenzaldehyde (126), 4-
isopropylbenzaldehyde (127), 3,4-dimethoxybenzaldehyde (128) and 4-
chlorobenzaldehyde (129) resulted in the formation of two series of chalcones, each 
consisting of five chalcones. These two series differ in the existence of prenyl 
substituents on ring A of the chalcone structure. Five chalcones bear O-prenyl and 
five others bear C-prenyl substituent with both series having the same substituents on 
ring B consisting of 4-(N,N-dimethyl)amino, 2-methoxy, 4-isopropyl, 3,4-dimethoxy 
and 4-chloro substituents. Chromanochalcone (152) was the sole compound 
successfully synthesized with the aid of prenylation of free hydroxyl group of the 
chromanacetophenone (133) precursor. All the synthetic compounds were screened 
for antibacterial activity by the micro dilution method against two bacteria strains, 
namely Gram positive (Staphylococcus aureus and Bacillus subtilis) and Gram 
negative (Pseudomonas aeruginosa and Escherichia coli). The compounds were also 
tested for 15-LOX assay using Lipoxygenase inhibitory screening assay kit (Item No. 
760700). All the synthetic compounds did not show activity against the bacteria 
tested, while compound (138) and (145) showed moderate lypoxygenase activity at 



















Rangka kalkon telah menarik ramai penyelidik untuk mengkaji laluan 
sintesis, keupayaan aktiviti biologi dan peranannya sebagai bahan perantara untuk 
rangka flavanoid semulajadi. Kajian ini memfokuskan kepada sintesis kalkon yang 
mempunyai penukarganti O-, C-prenil dan kromano. Sebatian sasaran ditulenkan 
dengan kaedah kromatografi dan struktur semua sebatian ditentukan dengan 
menggunakan kaedah spektroskopi inframerah (IM), resonans magnetik nuklear 
(RMN) dan spektrometri jisim (SJ). Prekursor terprenil telah disintesiskan bermula 
daripada 2,4-dihidroksiasetofenon (65) dan 2,4,6-trihidroksiasetofenon (93). 
Pemprenilan 2,4-dihidroksiasetofenon menggunakan prenil bromida telah 
dilaksanakan dengan jayanya bagi menghasilkan 2-hidroksi-4-O-prenilasetofenon 
(101). Tindak balas 2,4,6-trihidroksiasetofenon dengan prenil bromida dengan 
kehadiran bes telah menghasilkan satu campuran, dan penulenan kromatografi 
memberikan 2,4,6-trihidroksi-3-C-prenilasetofenon (132) dan 2,4-dihidroksi-5,6-
kromanasetofenon (133). Sebatian (133) telah diprenilkan kepada 2-hidroksi-4-O-
prenil-5,6-kromanasetofenon (136). C-prenilasetofenon (132) kemudian diubah 
kepada 2-hidroksi-3-C-prenil-4,6-dimetoksiasetofenon (137) menggunakan metil 
iodida dengan kehadiran kalium karbonat. Kondensasi Claisen-Schmidt O- dan C-
prenilasetofenon dengan benzaldehid individu, iaitu 4-(N,N-
dimetil)aminobenzaldehid (61), 2-metoksibenzaldehid (126), 4-isopropilbenzaldehid 
(127), 3,4-dimetoksibenzaldehid (128) dan 4-klorobenzaldehid (129) telah 
menghasilkan dua siri kalkon, tiap-tiap satu terdiri daripada lima kalkon. Dua siri ini 
berbeza dari segi kewujudan prenil pada gelang A struktur kalkon. Lima kalkon 
mempunyai O-prenil dan lima kalkon yang lain mempunyai penukar ganti C-prenil 
dengan kedua-dua siri mempunyai penukar ganti yang sama pada gelang B yang 
terdiri daripada penukar ganti 4-(N,N-dimetil)amino, 2-metoksi, 4-isopropil, 3,4-
dimetoksi and 4-kloro. Kromanokalkon (152) adalah sebatian tunggal yang berjaya 
disintesis dengan bantuan pemprenilan kumpulan hidroksil bebas pada prekursor 
kromanasetofenon (133). Semua sebatian sintetik telah disaring untuk aktiviti 
antibakteria menggunakan kaedah pencairan mikro terhadap dua jujukan bakteria 
iaitu Gram positif (Staphylococcus aureus dan Bacillus subtilis) dan Gram negatif 
(Pseudomonas aeruginosa dan Escherichia coli). Sebatian juga telah diuji untuk 
cerakin 15-LOX menggunakan kit cerakin saringan perencatan lipoksigenase (Item 
No. 760700). Semua sebatian sintetik tidak menunjukkan aktiviti terhadap bakteria 
yang diuji, manakala sebatian (138) dan (145) menunjukkan aktiviti lipoksigenase 
sederhana pada kepekatan 100 M dengan masing-masing mempunyai nilai 
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1.1 General Introduction 
 
 
Flavonoids are abundance group of polyphenolic substances which can be 
extracted in most plants and sometimes presence as glycosides [1]. Multiple 
combination of substituent such as hydroxyl, oxygen, methyl groups and sugars 
attached to these structures create the various classes of flavonoids (1), flavonols (2), 
flavanones (3), flavones (4), flavan-3-ols (5), anthocyanidins (6) and isoflavones (7). 
Flavonoids have shown capability as potential antitumor, antineoplastics activities, 

































Chalcone is the simplest flavonoid with a fifteen-carbon skeleton (C6-C3-C6) 
(8) which possessed two phenyl rings connected by three carbon bridges [2]. The 




association of cross aldol condensation of appropriate aldehydes and ketones, 





















Chalcone (8) are intermediates in the biosynthesis of flavonoids that 
widespread in plants and with an array of bioactivities [2]. Derivatives of chalcone 
are physiologically active compounds and become the substrates for the valuation of 
various organic syntheses [2]. Lipophilic prenyl side-chain attached to a chalcone 
moiety has been attracting the attention of the scientific community because of their 
myriad biological activities [4] which include O-prenylation, C-prenylation and 
chroman group [5]. Natural prenylated chalcones such as xanthohumol (9) exhibit 
numerous pharmacological properties such as antibacterial [6], antitumor [7], 











1.2 Problem Statement 
 
 
Owing to their simple structures and ease of preparation, chalcones 
intermediates for the synthesis of large number of derivatives of flavonoids. Besides 
prenylation, the pharmacological properties of chalcones also related to the presence, 




the synthesis of prenylated derivatives which include O-prenyl, C-prenyl, and 
chromane chalcones bearing hydroxyl and methoxyl substituents is undertaken. The 






1.3 Objectives of Study 
 
 
The objectives of this study are: 
 
 
1. To synthesis, purify and elucidate the acetophenone derivatives with O-
prenyl, C-prenyl and chromane as the side chains.  
2. To synthesis, purify, elucidate the series of O-prenyl, C-prenyl and 
chromanochalcones. 






1.4 Scope of Study 
 
 
The initial reactions were carried out by synthesizing O-prenyl, C-
prenylacetophenone and chromanacetophenone from 2,4-dihydroxyacetophenone 
and 2,4,6-trihydroxyacetophenone using prenyl bromide in the presence of either 1,8-
diazabicycloundec-7-ene (DBU) or K2CO3 as base without the use of protecting 
group. Mixtures of compounds were purified by recrystallization techniques or silica 
gel column chromatography (CC). Structures of O-prenyl, C-prenyl and 
chromanacetophenone were determined using IR and NMR (1D and 2D). 
Acetophenone derivatives were subjected to methylation using methyl iodide in 
K2CO3 followed by purification and structural elucidation. All characterized 
acetophenone derivatives were subjected to Claisen-Schmidt reaction with 
benzaldehyde derivatives which include benzaldehyde bearing substituents 4-(N,N-




chalcones. The reaction mixtures were purified by CC and the pure compounds were 
elucidated spectroscopically by IR, NMR and MS. The synthesized chalcones were 
screened for antibacterial and anti-inflammatory activities. Minimum inhibition 
concentration (MIC) using microdilution method was used as the tool to determine 
the antibacterial activity of the synthesized compounds against the Gram-positive 
and Gram-negative bacteria. Lipoxygenase assay (LOX) was used to screen the anti-
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